PLK1 and neoplasm: PLK1 also controls the nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) and interferon regulatory factor 3 signaling pathways, indicating that it may play a role in cellular immunity and inflammatory signaling, thereby influencing immune infiltration in the tumor microenvironment (TME).13